Early studies on fish oil and fat loss
Does it work in humans - what’s in it for me?
Fish oil as part of a non-dieting habitual lifestyle
Fish oil combined with exercise
Fish oil combined with a calorie restricted diet
Fish oil combined with a calorie restricted diet and exercise
Perspective on fish oil and fat loss
It’s getting better – fat loss combined with lean mass (muscle) gain
Mechanism – how does it work?
To maximize the fat loss and muscle growth effect of fish oil, aim for a daily fish oil dose that provides you with at least 1,900 mg (1.9 g) EPA and 1,500 mg (1.5 g) DHA. Ideally, strive to get at minimum about 4000 mg (4 g) EPA + DHA combined. As of this writing, there is not enough research data to make precise recommendations on any specific EPA-to-DHA ratio for fat loss.
1. Bilo, H.J. and R.O. Gans, Fish oil: a panacea? Biomed Pharmacother, 1990. 44(3): p. 169-74.
2. Swanson, D., R. Block, and S.A. Mousa, Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr, 2012. 3(1): p. 1-7.
3. McKenney, J.M. and D. Sica, Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy, 2007. 27(5): p. 715-28.
4. Egert, S. and P. Stehle, Impact of n-3 fatty acids on endothelial function: results from human interventions studies. Curr Opin Clin Nutr Metab Care, 2011. 14(2): p. 121-31.
5. Leeson, C.P., et al., Relationship between circulating n-3 fatty acid concentrations and endothelial function in early adulthood. Eur Heart J, 2002. 23(3): p. 216-22.
6. Haberka, M., et al., N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction: N-3 PUFA supplementation in acute myocardial infarction. Clin Nutr, 2011. 30(1): p. 79-85.
7. Fahs, C.A., et al., The effect of acute fish-oil supplementation on endothelial function and arterial stiffness following a high-fat meal. Appl Physiol Nutr Metab, 2010. 35(3): p. 294-302.
8. Wang, Q., et al., Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. Atherosclerosis, 2012. 221(2): p. 536-43.
9. Newens, K.J., et al., DHA-rich fish oil reverses the detrimental effects of saturated fatty acids on postprandial vascular reactivity. Am J Clin Nutr, 2011. 94(3): p. 742-8.
10. Lopez-Garcia, E., et al., Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr, 2004. 134(7): p. 1806-11.
11. Balakumar, P. and G. Taneja, Fish oil and vascular endothelial protection: bench to bedside. Free Radic Biol Med, 2012. 53(2): p. 271-9.
12. Tomiyama, H., et al., Do eicosapentaenoic acid supplements attenuate age-related increases in arterial stiffness in patients with dyslipidemia?: A preliminary study. Hypertens Res, 2005. 28(8): p. 651-5.
13. Ueshima, H., et al., Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure: INTERMAP study. Hypertension, 2007. 50(2): p. 313-9.
14. Liu, J.C., et al., Long-chain omega-3 fatty acids and blood pressure. Am J Hypertens, 2011. 24(10): p. 1121-6.
15. Mason, C.M., J. Long, and C. Conroy, Prescription Omega-3s: An Overview for Nurse Practitioners. J Cardiovasc Nurs, 2011. 26(4): p. 290-297.
16. Bays, H.E., et al., Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev Cardiovasc Ther, 2008. 6(3): p. 391-409.
17. Baillie, R.A., et al., Coordinate induction of peroxisomal acyl-CoA oxidase and UCP-3 by dietary fish oil: a mechanism for decreased body fat deposition. Prostaglandins Leukot Essent Fatty Acids, 1999. 60(5-6): p. 351-6.
18. Hill, J.O., et al., Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int J Obes Relat Metab Disord, 1993. 17(4): p. 223-36.
19. Ikemoto, S., et al., High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metabolism, 1996. 45(12): p. 1539-46.
20. Su, W. and P.J. Jones, Dietary fatty acid composition influences energy accretion in rats. J Nutr, 1993. 123(12): p. 2109-14.
21. Cunnane, S.C., K.R. McAdoo, and D.F. Horrobin, n-3 Essential fatty acids decrease weight gain in genetically obese mice. Br J Nutr, 1986. 56(1): p. 87-95.
22. LeBoeuf, R.C. and M.S. Veldee, Genetically determined body weight loss in mice fed diets containing salmon oil. J Nutr, 1993. 123(3): p. 547-58.
23. Mori, T., et al., Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57BL/6J mice. J Nutr, 2007. 137(12): p. 2629-34.
24. Pan, D.A. and L.H. Storlien, Dietary lipid profile is a determinant of tissue phospholipid fatty acid composition and rate of weight gain in rats. J Nutr, 1993. 123(3): p. 512-9.
25. Belzung, F., T. Raclot, and R. Groscolas, Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol, 1993. 264(6 Pt 2): p. R1111-8.
26. Parrish, C.C., D.A. Pathy, and A. Angel, Dietary fish oils limit adipose tissue hypertrophy in rats. Metabolism, 1990. 39(3): p. 217-9.
27. Ruzickova, J., et al., Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids, 2004. 39(12): p. 1177-85.
28. Couet, C., et al., Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord, 1997. 21(8): p. 637-43.
29. Kabir, M., et al., Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr, 2007. 86(6): p. 1670-9.
30. Delarue, J., et al., Effects of fish oil on metabolic responses to oral fructose and glucose loads in healthy humans. Am J Physiol, 1996. 270(2 Pt 1): p. E353-62.
31. Huffman, D.M., J.L. Michaelson, and T. Thomas, R. , Chronic supplementation with fish oil increases fat oxidation during exercise in young men. . JEPonline, 2004. 7(1): p. 48-56.
32. Hill, A.M., et al., Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. Am J Clin Nutr, 2007. 85(5): p. 1267-74.
33. Thorsdottir, I., et al., Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes (Lond), 2007. 31(10): p. 1560-6.
34. Kunesova, M., et al., The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res, 2006. 55(1): p. 63-72.
35. Brilla, L.R. and T.E. Landerholm, Effect of fish oil supplementation and exercise on serum lipids and aerobic fitness. J Sports Med Phys Fitness, 1990. 30(2): p. 173-80.
36. Warner, J.G., Jr., et al., Combined effects of aerobic exercise and omega-3 fatty acids in hyperlipidemic persons. Med Sci Sports Exerc, 1989. 21(5): p. 498-505.
37. Krebs, J.D., et al., Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond), 2006. 30(10): p. 1535-44.
38. DeFina, L.F., et al., Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. Am J Clin Nutr, 2011. 93(2): p. 455-62.
39. Noreen, E.E., et al., Effects of supplemental fish oil on resting metabolic rate, body composition, and salivary cortisol in healthy adults. J Int Soc Sports Nutr, 2010. 7: p. 31.
40. Clarke, S.D., Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Br J Nutr, 2000. 83 Suppl 1: p. S59-66.
41. Clarke, S.D., Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J Nutr, 2001. 131(4): p. 1129-32.
42. Clarke, S.D., The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr Opin Lipidol, 2004. 15(1): p. 13-8.
43. Clarke, S.D., et al., Fatty acid regulation of gene expression. Its role in fuel partitioning and insulin resistance. Ann N Y Acad Sci, 1997. 827: p. 178-87.
44. Clarke, S.D., et al., Fatty acid regulation of gene expression: a genomic explanation for the benefits of the mediterranean diet. Ann N Y Acad Sci, 2002. 967: p. 283-98.
45. Clarke, S.D. and D.B. Jump, Dietary polyunsaturated fatty acid regulation of gene transcription. Annu Rev Nutr, 1994. 14: p. 83-98.
46. Clarke, S.D., et al., Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors. Am J Clin Nutr, 1999. 70(4): p. 566-71.
47. Davidson, M.H., Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol, 2006. 98(4A): p. 27i-33i.
48. Jump, D.B., et al., Dietary polyunsaturated fatty acid regulation of gene transcription. Prog Lipid Res, 1996. 35(3): p. 227-41.
49. Jump, D.B., et al., Dietary fat, genes, and human health. Adv Exp Med Biol, 1997. 422: p. 167-76.
50. Nakamura, M.T., et al., Metabolism and functions of highly unsaturated fatty acids: an update. Lipids, 2001. 36(9): p. 961-4.
51. Ntambi, J.M. and H. Bene, Polyunsaturated fatty acid regulation of gene expression. J Mol Neurosci, 2001. 16(2-3): p. 273-8; discussion 279-84.
52. Price, P.T., C.M. Nelson, and S.D. Clarke, Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr Opin Lipidol, 2000. 11(1): p. 3-7.
53. Raclot, T. and H. Oudart, Selectivity of fatty acids on lipid metabolism and gene expression. Proc Nutr Soc, 1999. 58(3): p. 633-46.
54. Moustaid-Moussa, N. and C.D. Berdanier, Nutrient-Gene Interactions in Health and Disease. 2nd ed ed. 2001: CRC Press.
55. Berdanier, C.D. and N. Moustaid-Moussa, Genomics and Proteomics in Nutrition. 1st ed ed. 2004: CRC Press.
56. Lapillonne, A., S.D. Clarke, and W.C. Heird, Polyunsaturated fatty acids and gene expression. Curr Opin Clin Nutr Metab Care, 2004. 7(2): p. 151-6.
57. Hannah, V.C., et al., Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J Biol Chem, 2001. 276(6): p. 4365-72.
58. Kim, H.J., M. Takahashi, and O. Ezaki, Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs. J Biol Chem, 1999. 274(36): p. 25892-8.
59. Mater, M.K., et al., Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription. J Biol Chem, 1999. 274(46): p. 32725-32.
60. Nakatani, T., et al., A low fish oil inhibits SREBP-1 proteolytic cascade, while a high-fish-oil feeding decreases SREBP-1 mRNA in mice liver: relationship to anti-obesity. J Lipid Res, 2003. 44(2): p. 369-79.
61. Shimano, H., et al., Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem, 1999. 274(50): p. 35832-9.
62. Worgall, T.S., et al., Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J Biol Chem, 1998. 273(40): p. 25537-40.
63. Xu, J., et al., Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J Biol Chem, 1999. 274(33): p. 23577-83.
64. Yahagi, N., et al., A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J Biol Chem, 1999. 274(50): p. 35840-4.
65. Desvergne, B. and W. Wahli, Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev, 1999. 20(5): p. 649-88.
66. Kersten, S., B. Desvergne, and W. Wahli, Roles of PPARs in health and disease. Nature, 2000. 405(6785): p. 421-4.
67. Latruffe, N. and J. Vamecq, Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochimie, 1997. 79(2-3): p. 81-94.
68. Minnich, A., et al., A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle. Am J Physiol Endocrinol Metab, 2001. 280(2): p. E270-9.
69. Nakatani, T., et al., Mechanism for peroxisome proliferator-activated receptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes. J Biol Chem, 2002. 277(11): p. 9562-9.
70. Power, G.W. and E.A. Newsholme, Dietary fatty acids influence the activity and metabolic control of mitochondrial carnitine palmitoyltransferase I in rat heart and skeletal muscle. J Nutr, 1997. 127(11): p. 2142-50.
71. Schoonjans, K., B. Staels, and J. Auwerx, The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta, 1996. 1302(2): p. 93-109.
72. Krey, G., et al., Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol, 1997. 11(6): p. 779-91.
73. Reddy, J.K. and G.P. Mannaerts, Peroxisomal lipid metabolism. Annu Rev Nutr, 1994. 14: p. 343-70.
74. Delarue, J., et al., Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab, 2003. 29(3): p. 289-95.
75. Diez, J.J. and P. Iglesias, The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol, 2003. 148(3): p. 293-300.
76. Nedvidkova, J., et al., Adiponectin, an adipocyte-derived protein. Physiol Res, 2005. 54(2): p. 133-40.
77. Walker, B.R., Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence? Growth Horm IGF Res, 2001. 11 Suppl A: p. S91-5.
78. Salehi, M., A. Ferenczi, and B. Zumoff, Obesity and cortisol status. Horm Metab Res, 2005. 37(4): p. 193-7.
79. Bjorntorp, P. and R. Rosmond, Obesity and cortisol. Nutrition, 2000. 16(10): p. 924-36.
80. Pasquali, R., et al., The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci, 2006. 1083: p. 111-28.
81. Bays, H.E., et al., The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels. Postgrad Med, 2009. 121(5): p. 145-50.
Medical Writer & Nutritionist
University of Stockholm & Karolinska Institute, Sweden
Baylor University, TX, USA
Latest from Monica
- Hematocrit (blood thickness) elevation following testosterone therapy – does it increase risk of blood clots?
- Is there a protective role of testosterone against high-grade prostate cancer?
- Effects of testosterone treatment on body fat, lean mass, symptoms and leptin resistance in obese men on a calorie-restricted diet
- Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease: Real-Life Results
- Exercise – much more than just a calorie burning tool
- Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease: Real-Life Results
- Testosterone treatment is NOT associated with risk of adverse cardiovascular events – the RHYME study
- Video Summary: Testosterone Deficiency and Treatment - International Expert Consensus Resolutions
- Testosterone Deficiency and Treatment - the FACTS
- Real-life experience of continuous long-term testosterone therapy on anthropometric, endocrine and metabolic parameters for up to 10 years